BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28491224)

  • 1. [Macrophage activation syndrome complicating family lymphohistiocytosis].
    Boussaadni YE; Benajiba N; Bousfiha AA; Ailal F
    Pan Afr Med J; 2017; 26():93. PubMed ID: 28491224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
    Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
    Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.
    Minoia F; Bovis F; Davì S; Insalaco A; Lehmberg K; Shenoi S; Weitzman S; Espada G; Gao YJ; Anton J; Kitoh T; Kasapcopur O; Sanner H; Merino R; Astigarraga I; Alessio M; Jeng M; Chasnyk V; Nichols KE; Huasong Z; Li C; Micalizzi C; Ruperto N; Martini A; Cron RQ; Ravelli A; Horne A;
    J Pediatr; 2017 Oct; 189():72-78.e3. PubMed ID: 28807357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation syndrome in autoimmune disease.
    Deane S; Selmi C; Teuber SS; Gershwin ME
    Int Arch Allergy Immunol; 2010; 153(2):109-20. PubMed ID: 20407267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome.
    Valade S; Mariotte E; Azoulay E
    Crit Care Clin; 2020 Apr; 36(2):415-426. PubMed ID: 32172822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
    Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
    J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease.
    Simonini G; Pagnini I; Innocenti L; Calabri GB; De Martino M; Cimaz R
    Pediatr Blood Cancer; 2010 Sep; 55(3):592. PubMed ID: 20658642
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis.
    Signoff JK; Fitzgerald JC; Teachey DT; Balamuth F; Weiss SL
    Pediatr Crit Care Med; 2018 May; 19(5):397-405. PubMed ID: 29470247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage activation syndrome in pediatrics.
    Alongi A; Naddei R; De Miglio L; Natoli V; Ravelli A
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():13-15. PubMed ID: 32017214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 20-month-old boy with fever for 23 days.
    Klein-Gitelman MS
    Pediatr Ann; 2012 Mar; 41(3):e1-5. PubMed ID: 22390307
    [No Abstract]   [Full Text] [Related]  

  • 12. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin.
    Sztajnbok F; Fonseca AR; Campos LR; Lino K; Rodrigues MCF; Silva RM; de Almeida RG; Perazzio SF; Carvalho MFF
    Adv Rheumatol; 2024 Apr; 64(1):28. PubMed ID: 38627860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.
    Moling O; Piccin A; Tauber M; Marinello P; Canova M; Casini M; Negri G; Raffeiner B; Binazzi R; Gandini L; Vecchiato C; Rimenti G; Billio A
    J Med Case Rep; 2016 Sep; 10(1):254. PubMed ID: 27634631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Kumar B; Aleem S; Saleh H; Petts J; Ballas ZK
    J Clin Immunol; 2017 Oct; 37(7):638-643. PubMed ID: 28871523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
    Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
    Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
    Halyabar O; Chang MH; Schoettler ML; Schwartz MA; Baris EH; Benson LA; Biggs CM; Gorman M; Lehmann L; Lo MS; Nigrovic PA; Platt CD; Priebe GP; Rowe J; Sundel RP; Surana NK; Weinacht KG; Mann A; Yuen JC; Meleedy-Rey P; Starmer A; Banerjee T; Dedeoglu F; Degar BA; Hazen MM; Henderson LA
    Pediatr Rheumatol Online J; 2019 Feb; 17(1):7. PubMed ID: 30764840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Activation Syndrome in Scleroderma.
    Hone N; Donnelly C; Houk JB; Mina R
    J Clin Rheumatol; 2017 Mar; 23(2):120-121. PubMed ID: 28225516
    [No Abstract]   [Full Text] [Related]  

  • 19. Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma.
    Pascarella A; Bracaglia C; Caiello I; Arduini A; Moneta GM; Rossi MN; Matteo V; Pardeo M; De Benedetti F; Prencipe G
    Front Immunol; 2021; 12():663329. PubMed ID: 33815425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histiocytic disorders: recent insights into pathophysiology and practical guidelines.
    Filipovich A; McClain K; Grom A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S82-9. PubMed ID: 19932759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.